GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
82.06
-8.62 (-9.51%)
At close: Feb 20, 2026, 4:00 PM EST
88.33
+6.27 (7.63%)
After-hours: Feb 20, 2026, 7:57 PM EST
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.37 billion as of February 20, 2026. Its market cap has increased by 28.52% in one year.
Market Cap
2.37B
Enterprise Value
2.33B
1-Year Change
28.52%
Ranking
Category
Stock Price
$82.06
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.37B, a decrease of -86.75%. That is a compound annual growth rate of -31.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 2.37B | -36.91% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RadNet | 5.42B |
| Sotera Health Company | 4.97B |
| BillionToOne | 3.91B |
| Twist Bioscience | 2.98B |
| Veracyte | 2.82B |
| Neogen | 2.46B |
| GRAIL | 2.03B |
| NeoGenomics | 1.28B |